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We read with great interest the study by Moe
et al. (1) that assessed the effect of different
levels of parenteral phosphate and amino acids
on the growth of preterm infants, using body
weight as a surrogate for growth.
In preterm neonates, optimal parenteral
intakes of energy, amino acids and minerals
are necessary during the first days after birth
to mitigate the sudden interruption of high
intrauterine nutrient supply. This allows ade-
quate protein synthesis to support body growth,
including bone, using the intrauterine rate as a
reference. However, body weight reflects body
mass, which includes fat mass and a high
proportion of water, especially in preterm
neonates (2).
The variations in the supply of amino acid
and phosphate would mainly have an impact
on lean mass, including bone, which is better
assessed clinically by crown to heel length than
by weight. In fact, amino acids and phosphate
are major determinants of the muscle and the
bone matrix, and thus of skeletal growth. It is
understandable that crown to heel length
measurements were not considered sufficiently
reliable in a retrospective analysis, because
even prospectively accurate measurements in
neonates are not easy to carry out.
Moe et al. (1) concluded that parenteral
solutions with high amino acids and high
phosphate content do not provide higher
catch-up growth than solutions with high
amino acids and low phosphate content.
In addition to the graphical evidence, the
authors base this conclusion on the statistical
analysis of serial measurements of both
serum phosphate and the weight standard
score (Z-score). A univariable analysis was
performed based on the change in the weight
Z-score from birth up to 29 days of age. The
conclusions would have been stronger and
more reliable if the analysis had taken into
account three aspects: (i) the longitudinal
character of the repeated measurements, that
were available; (ii) the influence of factors
that may also affect the outcome, such as
being small for gestational age or receiving
additional phosphate supply; and (iii) the
interference from the lack of independence
of the observations from twins and other
multiples. Therefore, we consider that using
mixed-effects regression models to carry out a
multivariable analysis of the available longi-
tudinal, repeated measurements would even-
tually demonstrate the lack of effectiveness of
the solutions with high amino acids and high
phosphate content more accurately than the
performed analysis.
The results of this important study will
encourage further research into which body
compartments are more influenced by varia-
tions in amino acids and phosphate supply.
Using noninvasive, accurate methods such as
air displacement plethysmography and quan-
titative ultrasound to measure lean mass,
segmental length and bone strength would
provide more informative data. Furthermore,
friendlier and potent statistical tools that can be
used to analyse longitudinal data have recently
become available, and these allow more
powerful statistical hypotheses tests and more
accurate estimates of effect size (3).
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